Two independent studies used a high-throughput, cell-based screen to identify compounds that promote the inclusion of a skipped exon in SMN2 pre-mRNA, thus restoring the expression of the SMN protein that is lacking in patients with spinal muscular atrophy (9, 10). Here, SMN2 is linked to spinal muscular atrophy.